Myriad Genetics
MYGN
#7886
Rank
NZ$0.73 B
Marketcap
NZ$7.68
Share price
2.62%
Change (1 day)
-41.40%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -NZ$0.64 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are NZ$0.82 Billion. In 2025 the company made an earning of -NZ$0.69 Billion a decrease over its 2024 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.64 Billion-6.8%
2025 -NZ$0.69 Billion218.91%
2024 -NZ$0.22 Billion-53.49%
2023 -NZ$0.47 Billion88.72%
2022 -NZ$0.25 Billion172.08%
2021 -NZ$89.99 Million
2019 -NZ$46.87 Million-175.14%
2018 NZ$62.36 M-70.81%
2017 NZ$0.21 B22.22%
2016 NZ$0.17 B-38.8%
2015 NZ$0.28 B-6.12%
2014 NZ$0.30 B-41.07%
2013 NZ$0.51 B46.67%
2012 NZ$0.35 B15.84%
2011 NZ$0.30 B17.6%
2010 NZ$0.25 B-15.96%
2009 NZ$0.30 B
2007 -NZ$74.27 Million40.96%
2006 -NZ$52.69 Million
2003 -NZ$61.18 Million34.8%
2002 -NZ$45.39 Million89.21%
2001 -NZ$23.99 Million3.93%
2000 -NZ$23.09 Million21.76%
1999 -NZ$18.96 Million-25.61%
1998 -NZ$25.49 Million38.83%
1997 -NZ$18.36 Million-24.26%
1996 -NZ$24.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$14.49 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-NZ$0.33 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B-138.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$62.31 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$0.62 B-190.78%๐Ÿ‡บ๐Ÿ‡ธ USA